University Of Texas Southwestern

In patients with basal insulin-treated type 2 diabetes, sotagliflozin was associated with greater time in range compared with placebo at 18 weeks, researchers reported at the European Association for the Study of Diabetes Annual Meeting.

ORLANDO — Semaglutide reduces risk for cardiovascular events among adults with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or change in HbA1c, according to data from the SELECT trial.

Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone.

Individuals recently diagnosed with cancer frequently decide on their own to visit hospital emergency departments for symptoms that do not require immediate care, according to a study conducted at UT Southwestern Medical Center.

DALLAS — Oral semaglutide improves HbA1c and may prevent progression to type 2 diabetes for adults with prediabetes, according to a speaker at ObesityWeek.

SAN DIEGO — Adults with obesity and type 2 diabetes achieved a 14.7% weight loss at 72 weeks with 15 mg tirzepatide, according to data from the SURMOUNT-2 trial presented at the American Diabetes Association Scientific Sessions.

Editor’s note: This is the second in a series of five stories from ASCO Voices, a session during ASCO Annual Meeting focused on the human side of oncology.

I did not choose rheumatology — it chose me.

Sufficient disease control prior to conception can reduce the risk for pregnancy complications in patients with rheumatic conditions, according to a press release announcing data published in Rheumatic Disease Clinics of North America.

Nearly 30% of adults with obesity gained 5% or more body weight during the COVID-19 pandemic, and those who gained weight were more likely to have depression and engage in unhealthy eating, according to study data.